TABLE 1.
The Newcastle–Ottawa scale (NOS) of studies included.
Study | Selection |
Comparability |
Outcome assessment |
Total score | ||||||
1 | 2 | 3 | 4 | 1 | 2 | 1 | 2 | 3 | ||
Barakat et al. (23) | + | + | + | + | + | + | + | 7 | ||
Mercier et al. (11) | + | + | + | + | + | + | 6 | |||
Lin et al. (24) | + | + | + | + | + | + | + | 7 | ||
Asenov et al. (25) | + | + | + | + | + | + | 6 | |||
Harputluoglu et al. (26) | + | + | + | + | + | + | + | + | 8 | |
Wen et al. (27) | + | + | + | + | + | + | + | 7 | ||
Zeng et al. (28) | + | + | + | + | + | + | + | 7 | ||
Kohoutova et al. (29) | + | + | + | + | + | + | 6 | |||
Czubkowski et al. (13) | + | + | + | + | + | + | + | 7 | ||
Rosen et al. (30) | + | + | + | + | + | + | + | + | 8 | |
Giefer and Kozarek (31) | + | + | + | + | + | + | + | + | 8 | |
Dechêne et al. (32) | + | + | + | + | + | + | 5 | |||
Kargl et al. (33) | + | + | + | + | + | + | 6 | |||
Agarwal et al. (34) | + | + | + | + | + | + | + | 7 | ||
Oracz et al. (35) | + | + | + | + | + | + | 6 | |||
Steen et al. (36) | + | + | + | + | + | + | 6 | |||
Tsuchiya et al. (16) | + | + | + | + | 5 | |||||
Limketkai et al. (37) | + | + | + | + | + | + | 6 | |||
Enestvedt et al. (38) | + | + | + | + | + | + | 6 | |||
Otto et al. (39) | + | + | + | + | + | + | + | 7 | ||
Berquist (40) | + | + | + | + | + | 5 | ||||
Otto et al. (41) | + | + | + | + | + | + | + | 7 | ||
Jang et al. (42) | + | + | + | + | + | + | + | 7 | ||
Li et al. (18) | + | + | + | + | + | + | + | + | 8 | |
Vegting et al. (43) | + | + | + | + | + | + | 6 | |||
Issa et al. (17) | + | + | + | + | + | + | 6 | |||
Rocca et al. (1) | + | + | + | + | + | + | + | 7 | ||
Cheng et al. (44) | + | + | + | + | + | + | + | + | 8 | |
Varadarajulu et al. (45) | + | + | + | + | + | + | + | 7 | ||
Pfau et al. (46) | + | + | + | + | + | + | 6 | |||
Poddar et al. (47) | + | + | + | + | + | + | + | 7 | ||
Hsu et al. (48) | + | + | + | + | + | + | + | 7 | ||
Guelrud et al. (49) | + | + | + | + | + | + | 6 |
Selection:
1: Representativeness of the exposed cohort.
2: Selection of the non-exposed cohort.
3: Ascertainment of exposure.
4: Demonstration that outcome of interest was not present at start of study.
Outcome assessment:
1: Assessment of outcome.
2: Follow-up long enough for outcomes to occur.
3: Adequacy of follow up of cohorts.
Comparability: study controls for the most important factor or any additional factor.